Cargando…

A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma

BACKGROUND: Improved usage of the repertoires of pancreatic ductal adenocarcinoma (PDAC) profiles is crucially needed to guide the development of predictive and prognostic tools that could inform the selection of treatment options. METHODS: Using publicly available mRNA abundance datasets, we perfor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haider, Syed, Wang, Jun, Nagano, Ai, Desai, Ami, Arumugam, Prabhu, Dumartin, Laurent, Fitzgibbon, Jude, Hagemann, Thorsten, Marshall, John F, Kocher, Hemant M, Crnogorac-Jurcevic, Tatjana, Scarpa, Aldo, Lemoine, Nicholas R, Chelala, Claude
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293116/ https://www.ncbi.nlm.nih.gov/pubmed/25587357 http://dx.doi.org/10.1186/s13073-014-0105-3

Ejemplares similares

Splice variants as novel targets in pancreatic ductal adenocarcinoma
por: Wang, Jun, et al.
Publicado: (2017)

A global insight into a cancer transcriptional space using pancreatic data: importance, findings and flaws
por: Gadaleta, Emanuela, et al.
Publicado: (2011)

The Pancreatic Expression Database: 2018 update
por: Marzec, Jacek, et al.
Publicado: (2018)

The Pancreatic Expression database: 2011 update
por: Cutts, Rosalind J., et al.
Publicado: (2011)

Molecular Analysis of Precursor Lesions in Familial Pancreatic Cancer
por: Crnogorac-Jurcevic, Tatjana, et al.
Publicado: (2013)

Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma
por: Goulart, Michelle R., et al.
Publicado: (2021)

Nutraceuticals as Supportive Therapeutic Agents in Diabetes and Pancreatic Ductal Adenocarcinoma: A Systematic Review
por: Mikolaskova, Iveta, et al.
Publicado: (2023)

Pancreatic Expression database: a generic model for the organization, integration and mining of complex cancer datasets
por: Chelala, Claude, et al.
Publicado: (2007)

The pancreatic expression database: recent extensions and updates
por: Dayem Ullah, Abu Z., et al.
Publicado: (2014)

Response to the comment on “Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients”
por: Blyuss, Oleg, et al.
Publicado: (2020)

ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation
por: Dumartin, L, et al.
Publicado: (2017)

AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting
por: Liu, Alvin Y., et al.
Publicado: (2019)

Pancreatic stellate cells regulate blood vessel density in the stroma of pancreatic ductal adenocarcinoma
por: Di Maggio, Francesco, et al.
Publicado: (2016)

Perineural invasion in pancreatic cancer: proteomic analysis and in vitro modelling
por: Alrawashdeh, Wasfi, et al.
Publicado: (2019)

Non-Invasive Biomarkers for Earlier Detection of Pancreatic Cancer—A Comprehensive Review
por: Brezgyte, Greta, et al.
Publicado: (2021)

Demographic, clinical, and pathological features of early onset pancreatic cancer patients
por: Ntala, Chara, et al.
Publicado: (2018)

MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapy
por: Baleeiro, Renato B., et al.
Publicado: (2022)

Non-Invasive Biomarkers for Early Lung Cancer Detection
por: Saman, Harman, et al.
Publicado: (2022)

Genomic analysis reveals epigenetic ‘addiction’ underpinning follicular lymphoma and its transformation – a rationale for targeted epigenetic therapies
por: Okosun, Jessica, et al.
Publicado: (2013)

The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy
por: Reader, Claire S, et al.
Publicado: (2019)

SNPnexus: assessing the functional relevance of genetic variation to facilitate the promise of precision medicine
por: Dayem Ullah, Abu Z, et al.
Publicado: (2018)

Differentiating Ductal Adenocarcinoma of the Pancreas from Benign Conditions Using Routine Health Records: A Prospective Case-Control Study
por: Zardab, Mohamed, et al.
Publicado: (2022)

COVID-19 in patients with hepatobiliary and pancreatic diseases: a single-centre cross-sectional study in East London
por: Dayem Ullah, Abu Z M, et al.
Publicado: (2021)

Temporality of clinical factors associated with pancreatic cancer: a case-control study using linked electronic health records
por: Dayem Ullah, Abu Z. M., et al.
Publicado: (2021)

S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer
por: Srivastava, K., et al.
Publicado: (2023)

Lymphoepithelial Cyst of the Pancreas
por: Arumugam, Prabhu, et al.
Publicado: (2016)

Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors
por: Barry, Sayka, et al.
Publicado: (2019)

Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
por: Sivapalan, Lavanya, et al.
Publicado: (2022)

A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case–control study
por: Debernardi, Silvana, et al.
Publicado: (2020)

Role of laparoscopy in hepatobiliary malignancies
por: Arumugam, Prabhu, et al.
Publicado: (2016)

SNPnexus: a web database for functional annotation of newly discovered and public domain single nucleotide polymorphisms
por: Chelala, Claude, et al.
Publicado: (2009)

‘Multi-omic’ data analysis using O-miner
por: Sangaralingam, Ajanthah, et al.
Publicado: (2017)

Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients
por: Blyuss, Oleg, et al.
Publicado: (2019)

Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis
por: Debernardi, Silvana, et al.
Publicado: (2022)

SNPnexus: a web server for functional annotation of novel and publicly known genetic variants (2012 update)
por: Dayem Ullah, Abu Z., et al.
Publicado: (2012)

PAK4 interacts with p85 alpha: implications for pancreatic cancer cell migration
por: King, Helen, et al.
Publicado: (2017)

Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy
por: Mortoglou, Maria, et al.
Publicado: (2021)

Using BioMart as a framework to manage and query pancreatic cancer data
por: Cutts, Rosalind J., et al.
Publicado: (2011)

SONOELASTOGRAPHIC FEATURES OF HIGH-RISK BREAST LESIONS AND DUCTAL CARCINOMA IN SITU – A PILOT STUDY
por: Crnogorac, Maja, et al.
Publicado: (2019)

Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis
por: Moore, P S, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_rop5duru21jge4bafgojkhs9bl